Divi's Laboratories Limited (BOM: 532488)
India
· Delayed Price · Currency is INR
5,844.75
0.00 (0.00%)
At close: Dec 20, 2024
Divi's Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Operating Revenue | 86,140 | 78,450 | 77,670 | 89,598 | 69,694 | 53,944 | Upgrade
|
Other Revenue | - | - | - | 0.9 | 0.7 | 0.5 | Upgrade
|
Revenue | 86,140 | 78,450 | 77,670 | 89,599 | 69,695 | 53,945 | Upgrade
|
Revenue Growth (YoY) | 17.27% | 1.00% | -13.31% | 28.56% | 29.20% | 9.06% | Upgrade
|
Cost of Revenue | 36,760 | 33,520 | 32,740 | 31,605 | 24,718 | 22,456 | Upgrade
|
Gross Profit | 49,380 | 44,930 | 44,930 | 57,995 | 44,977 | 31,489 | Upgrade
|
Selling, General & Admin | 11,730 | 11,060 | 9,870 | 9,571 | 8,367 | 6,317 | Upgrade
|
Other Operating Expenses | 12,000 | 11,780 | 11,370 | 9,583 | 7,906 | 6,918 | Upgrade
|
Operating Expenses | 27,590 | 26,620 | 24,670 | 22,269 | 18,829 | 15,097 | Upgrade
|
Operating Income | 21,790 | 18,310 | 20,260 | 35,726 | 26,148 | 16,392 | Upgrade
|
Interest Expense | -30 | -30 | - | -3.7 | -3.9 | -55.4 | Upgrade
|
Interest & Investment Income | 3,010 | 3,010 | 2,050 | 689.6 | 572.4 | 440.3 | Upgrade
|
Currency Exchange Gain (Loss) | 440 | 300 | 1,300 | 405.8 | -43.8 | 821.1 | Upgrade
|
Other Non Operating Income (Expenses) | 60 | 30 | 40 | 38.1 | 21.2 | 34.9 | Upgrade
|
EBT Excluding Unusual Items | 25,270 | 21,620 | 23,650 | 36,856 | 26,694 | 17,633 | Upgrade
|
Gain (Loss) on Sale of Investments | 50 | 50 | 50 | - | 26.5 | 593.9 | Upgrade
|
Gain (Loss) on Sale of Assets | -40 | -40 | -10 | -20.5 | -59.6 | -32.5 | Upgrade
|
Pretax Income | 25,280 | 21,630 | 23,690 | 36,835 | 26,660 | 18,195 | Upgrade
|
Income Tax Expense | 6,920 | 5,630 | 5,450 | 7,231 | 6,818 | 4,429 | Upgrade
|
Net Income | 18,360 | 16,000 | 18,240 | 29,605 | 19,843 | 13,765 | Upgrade
|
Net Income to Common | 18,360 | 16,000 | 18,240 | 29,605 | 19,843 | 13,765 | Upgrade
|
Net Income Growth | 37.90% | -12.28% | -38.39% | 49.19% | 44.15% | 1.76% | Upgrade
|
Shares Outstanding (Basic) | 266 | 265 | 265 | 265 | 265 | 265 | Upgrade
|
Shares Outstanding (Diluted) | 266 | 265 | 265 | 265 | 265 | 265 | Upgrade
|
Shares Change (YoY) | 0.03% | - | - | - | - | - | Upgrade
|
EPS (Basic) | 69.15 | 60.27 | 68.71 | 111.52 | 74.75 | 51.85 | Upgrade
|
EPS (Diluted) | 69.15 | 60.27 | 68.69 | 111.52 | 74.75 | 51.85 | Upgrade
|
EPS Growth | 37.86% | -12.26% | -38.40% | 49.19% | 44.16% | 1.75% | Upgrade
|
Free Cash Flow | 4,750 | 2,580 | 19,860 | 11,986 | 10,367 | 327.3 | Upgrade
|
Free Cash Flow Per Share | 17.89 | 9.72 | 74.81 | 45.15 | 39.05 | 1.23 | Upgrade
|
Dividend Per Share | - | 30.000 | 30.000 | 30.000 | 20.000 | 16.000 | Upgrade
|
Dividend Growth | - | 0% | 0% | 50.00% | 25.00% | 0% | Upgrade
|
Gross Margin | 57.33% | 57.27% | 57.85% | 64.73% | 64.53% | 58.37% | Upgrade
|
Operating Margin | 25.30% | 23.34% | 26.08% | 39.87% | 37.52% | 30.39% | Upgrade
|
Profit Margin | 21.31% | 20.40% | 23.48% | 33.04% | 28.47% | 25.52% | Upgrade
|
Free Cash Flow Margin | 5.51% | 3.29% | 25.57% | 13.38% | 14.88% | 0.61% | Upgrade
|
EBITDA | 25,610 | 22,050 | 23,640 | 38,801 | 28,666 | 18,224 | Upgrade
|
EBITDA Margin | 29.73% | 28.11% | 30.44% | 43.30% | 41.13% | 33.78% | Upgrade
|
D&A For EBITDA | 3,820 | 3,740 | 3,380 | 3,075 | 2,518 | 1,832 | Upgrade
|
EBIT | 21,790 | 18,310 | 20,260 | 35,726 | 26,148 | 16,392 | Upgrade
|
EBIT Margin | 25.30% | 23.34% | 26.08% | 39.87% | 37.52% | 30.39% | Upgrade
|
Effective Tax Rate | 27.37% | 26.03% | 23.01% | 19.63% | 25.57% | 24.34% | Upgrade
|
Revenue as Reported | 89,700 | 81,840 | 81,120 | 90,737 | 70,320 | 55,841 | Upgrade
|
Advertising Expenses | - | - | - | 1.6 | 0.7 | 9.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.